Cargando…

Sleep apnea and the impact on cardiovascular risk in patients with Marfan syndrome

BACKGROUND: Marfan syndrome (MFS) is an inherited connective tissue disorder characterized by ectopia lentis, aortic root dilation and dissection and specific skeletal features. Obstructive sleep apnea (OSA) in MFS has been described earlier but the prevalence and its relation with the cardiovascula...

Descripción completa

Detalles Bibliográficos
Autores principales: Muiño‐Mosquera, Laura, Bauters, Fré, Dhondt, Karlien, De Wilde, Hans, Jordaens, Luc, De Groote, Katya, De Wolf, Daniel, Hertegonne, Katrien, De Backer, Julie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6687621/
https://www.ncbi.nlm.nih.gov/pubmed/31245936
http://dx.doi.org/10.1002/mgg3.805
_version_ 1783442741718417408
author Muiño‐Mosquera, Laura
Bauters, Fré
Dhondt, Karlien
De Wilde, Hans
Jordaens, Luc
De Groote, Katya
De Wolf, Daniel
Hertegonne, Katrien
De Backer, Julie
author_facet Muiño‐Mosquera, Laura
Bauters, Fré
Dhondt, Karlien
De Wilde, Hans
Jordaens, Luc
De Groote, Katya
De Wolf, Daniel
Hertegonne, Katrien
De Backer, Julie
author_sort Muiño‐Mosquera, Laura
collection PubMed
description BACKGROUND: Marfan syndrome (MFS) is an inherited connective tissue disorder characterized by ectopia lentis, aortic root dilation and dissection and specific skeletal features. Obstructive sleep apnea (OSA) in MFS has been described earlier but the prevalence and its relation with the cardiovascular risk is still controversial. This study aimed to further investigate these aspects. METHODS: In this prospective longitudinal study, we performed an attended polysomnography in 40 MFS patients (60% women, 37 ± 12.8 years) and evaluated several cardiovascular parameters through echocardiography, resting electrocardiogram, 24 hr‐Holter monitoring and serum NT‐ProBNP measurements. RESULTS: We found that OSA was present in 42.5% of the patients and that higher body mass index was the most important factor associated with the presence of OSA. We observed that overweight was present in 27.5% of the patients in the whole cohort and in 55.6% if >40 years. Furthermore, when evaluating the impact of OSA on the cardiovascular system, we observed that patients with OSA tended to have higher systolic blood pressure, larger distal aortic diameters and a higher prevalence of ventricular arrhythmia. These differences were, however, not significant after adjusting for confounders. CONCLUSIONS: Our study shows a high prevalence of OSA and a high prevalence of overweight in MFS patients. We found some trends between OSA and cardiovascular features but we could not establish a solid association. Our study, however might be underpowered, and a multicenter collaborative study could be very useful to answer some important open questions.
format Online
Article
Text
id pubmed-6687621
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-66876212019-08-14 Sleep apnea and the impact on cardiovascular risk in patients with Marfan syndrome Muiño‐Mosquera, Laura Bauters, Fré Dhondt, Karlien De Wilde, Hans Jordaens, Luc De Groote, Katya De Wolf, Daniel Hertegonne, Katrien De Backer, Julie Mol Genet Genomic Med Original Articles BACKGROUND: Marfan syndrome (MFS) is an inherited connective tissue disorder characterized by ectopia lentis, aortic root dilation and dissection and specific skeletal features. Obstructive sleep apnea (OSA) in MFS has been described earlier but the prevalence and its relation with the cardiovascular risk is still controversial. This study aimed to further investigate these aspects. METHODS: In this prospective longitudinal study, we performed an attended polysomnography in 40 MFS patients (60% women, 37 ± 12.8 years) and evaluated several cardiovascular parameters through echocardiography, resting electrocardiogram, 24 hr‐Holter monitoring and serum NT‐ProBNP measurements. RESULTS: We found that OSA was present in 42.5% of the patients and that higher body mass index was the most important factor associated with the presence of OSA. We observed that overweight was present in 27.5% of the patients in the whole cohort and in 55.6% if >40 years. Furthermore, when evaluating the impact of OSA on the cardiovascular system, we observed that patients with OSA tended to have higher systolic blood pressure, larger distal aortic diameters and a higher prevalence of ventricular arrhythmia. These differences were, however, not significant after adjusting for confounders. CONCLUSIONS: Our study shows a high prevalence of OSA and a high prevalence of overweight in MFS patients. We found some trends between OSA and cardiovascular features but we could not establish a solid association. Our study, however might be underpowered, and a multicenter collaborative study could be very useful to answer some important open questions. John Wiley and Sons Inc. 2019-06-27 /pmc/articles/PMC6687621/ /pubmed/31245936 http://dx.doi.org/10.1002/mgg3.805 Text en © 2019 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Muiño‐Mosquera, Laura
Bauters, Fré
Dhondt, Karlien
De Wilde, Hans
Jordaens, Luc
De Groote, Katya
De Wolf, Daniel
Hertegonne, Katrien
De Backer, Julie
Sleep apnea and the impact on cardiovascular risk in patients with Marfan syndrome
title Sleep apnea and the impact on cardiovascular risk in patients with Marfan syndrome
title_full Sleep apnea and the impact on cardiovascular risk in patients with Marfan syndrome
title_fullStr Sleep apnea and the impact on cardiovascular risk in patients with Marfan syndrome
title_full_unstemmed Sleep apnea and the impact on cardiovascular risk in patients with Marfan syndrome
title_short Sleep apnea and the impact on cardiovascular risk in patients with Marfan syndrome
title_sort sleep apnea and the impact on cardiovascular risk in patients with marfan syndrome
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6687621/
https://www.ncbi.nlm.nih.gov/pubmed/31245936
http://dx.doi.org/10.1002/mgg3.805
work_keys_str_mv AT muinomosqueralaura sleepapneaandtheimpactoncardiovascularriskinpatientswithmarfansyndrome
AT bautersfre sleepapneaandtheimpactoncardiovascularriskinpatientswithmarfansyndrome
AT dhondtkarlien sleepapneaandtheimpactoncardiovascularriskinpatientswithmarfansyndrome
AT dewildehans sleepapneaandtheimpactoncardiovascularriskinpatientswithmarfansyndrome
AT jordaensluc sleepapneaandtheimpactoncardiovascularriskinpatientswithmarfansyndrome
AT degrootekatya sleepapneaandtheimpactoncardiovascularriskinpatientswithmarfansyndrome
AT dewolfdaniel sleepapneaandtheimpactoncardiovascularriskinpatientswithmarfansyndrome
AT hertegonnekatrien sleepapneaandtheimpactoncardiovascularriskinpatientswithmarfansyndrome
AT debackerjulie sleepapneaandtheimpactoncardiovascularriskinpatientswithmarfansyndrome